Annual D&A
$1.73 M
+$1.19 M+221.93%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual depreciation & amortization is $1.73 million, with the most recent change of +$1.19 million (+221.93%) on December 31, 2023.
- During the last 3 years, EWTX annual D&A has risen by +$1.55 million (+836.22%).
- EWTX annual D&A is now at all-time high.
Performance
EWTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$602.00 K
+$68.00 K+12.73%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly depreciation & amortization is $602.00 thousand, with the most recent change of +$68.00 thousand (+12.73%) on September 30, 2024.
- Over the past year, EWTX quarterly D&A has increased by +$105.00 thousand (+21.13%).
- EWTX quarterly D&A is now at all-time high.
Performance
EWTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.19 M
+$105.00 K+5.03%
September 30, 2024
Summary
- As of February 7, 2025, EWTX TTM depreciation & amortization is $2.19 million, with the most recent change of +$105.00 thousand (+5.03%) on September 30, 2024.
- Over the past year, EWTX TTM D&A has increased by +$903.00 thousand (+69.95%).
- EWTX TTM D&A is now at all-time high.
Performance
EWTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
EWTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +221.9% | +21.1% | +70.0% |
| 3 y3 years | +836.2% | +21.1% | +70.0% |
| 5 y5 years | +1308.1% | +21.1% | +70.0% |
EWTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +536.8% | at high | +671.8% | at high | +706.6% |
| 5 y | 5-year | at high | +1308.1% | at high | +1405.0% | at high | +5385.0% |
| alltime | all time | at high | +1308.1% | at high | +1405.0% | at high | +5385.0% |
Edgewise Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $602.00 K(+12.7%) | $2.19 M(+5.0%) |
| Jun 2024 | - | $534.00 K(+1.7%) | $2.09 M(+3.6%) |
| Mar 2024 | - | $525.00 K(-1.5%) | $2.02 M(+16.4%) |
| Dec 2023 | $1.73 M(+221.9%) | $533.00 K(+7.2%) | $1.73 M(+34.2%) |
| Sep 2023 | - | $497.00 K(+7.8%) | $1.29 M(+34.6%) |
| Jun 2023 | - | $461.00 K(+91.3%) | $959.00 K(+47.1%) |
| Mar 2023 | - | $241.00 K(+162.0%) | $652.00 K(+21.2%) |
| Dec 2022 | $538.00 K | $92.00 K(-44.2%) | $538.00 K(+2.7%) |
| Sep 2022 | - | $165.00 K(+7.1%) | $524.00 K(+23.9%) |
| Jun 2022 | - | $154.00 K(+21.3%) | $423.00 K(+32.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $127.00 K(+62.8%) | $320.00 K(+17.6%) |
| Dec 2021 | $272.00 K(+47.0%) | $78.00 K(+21.9%) | $272.00 K(+11.5%) |
| Sep 2021 | - | $64.00 K(+25.5%) | $244.00 K(+6.1%) |
| Jun 2021 | - | $51.00 K(-35.4%) | $230.00 K(+2.7%) |
| Mar 2021 | - | $79.00 K(+58.0%) | $224.00 K(+21.1%) |
| Dec 2020 | $185.00 K(+50.4%) | $50.00 K(0.0%) | $185.00 K(+37.0%) |
| Sep 2020 | - | $50.00 K(+11.1%) | $135.00 K(+58.8%) |
| Jun 2020 | - | $45.00 K(+12.5%) | $85.00 K(+112.5%) |
| Mar 2020 | - | $40.00 K | $40.00 K |
| Dec 2019 | $123.00 K | - | - |
FAQ
- What is Edgewise Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual D&A year-on-year change?
- What is Edgewise Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly D&A year-on-year change?
- What is Edgewise Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM D&A year-on-year change?
What is Edgewise Therapeutics annual depreciation & amortization?
The current annual D&A of EWTX is $1.73 M
What is the all time high annual D&A for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual depreciation & amortization is $1.73 M
What is Edgewise Therapeutics annual D&A year-on-year change?
Over the past year, EWTX annual depreciation & amortization has changed by +$1.19 M (+221.93%)
What is Edgewise Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of EWTX is $602.00 K
What is the all time high quarterly D&A for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly depreciation & amortization is $602.00 K
What is Edgewise Therapeutics quarterly D&A year-on-year change?
Over the past year, EWTX quarterly depreciation & amortization has changed by +$105.00 K (+21.13%)
What is Edgewise Therapeutics TTM depreciation & amortization?
The current TTM D&A of EWTX is $2.19 M
What is the all time high TTM D&A for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM depreciation & amortization is $2.19 M
What is Edgewise Therapeutics TTM D&A year-on-year change?
Over the past year, EWTX TTM depreciation & amortization has changed by +$903.00 K (+69.95%)